Reciprocity agreement between ESVB and SOLACI

On behalf of all who make part of SOLACI, we are thrilled to announce a reciprocity and mutual collaboration agreement with the European Symposium of Vascular Biomaterials (ESVB). This association will allow us to create new relationships with important European professionals in the field and, in time, enhance and strengthen the presence of SOLACI worldwide. 

esvb_2017_02_october_12-14-2017-bis

This year, the ESVB celebrates the tenth edition of their annual symposium, which will take place on October 12 to 14, 2017, in Strasburg, France. This event is a great opportunity to meet renowned scientists and researchers from all over the world involved in the study and usability of vascular and endovascular biomaterials.

 

The main topics will be:

  • Vascular and endovascular device durability.
  • The latest trends in pre-surgery imaging technology.
  • Tissue, plaque and vascular wall properties and endovascular technologies.
  • Updates on state of the art endovascular technology by experts.

 

You may see the preliminary program or obtain more information on the Congress .

 

We will soon publish more information.

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....